ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update
March 18, 2019Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has closed a private placement financing for gross proc
Pharma Sources Insight January 2025
